Title: Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
Journal: Journal of medicinal chemistry 20010802
188247-01-0
188860-26-6
23491-52-3
158013-42-4
158013-41-3
158013-43-5
1334179-85-9 | Bttaa | AA009CJD | MFCD29918287
1247367-86-7 | BenzeneMethanol, 2-Methyl-4-(1H-pyrazol-1-yl)- | AA009CVS | MFCD16686747
1257535-49-1 | 3-Amino-5-azaindole diHCl | AA009DAP | MFCD16628055
135830-04-5 | 1-Methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile | AA009DO9 | MFCD13188581
13573-51-8 | 4-(1,1-DIBUTYL-PENTYL)-PYRIDINE | AA009DTD | MFCD06637483
1330171-28-2 | 5-Sulfooxymethylfurfural Sodium Salt | AA009DXP | MFCD01753038
1233937-39-7 | Vitamin K1-d7 | AA009E3N | MFCD11656108
1242184-41-3 | Diltiazem-d6 | AA009EBR
1246820-30-3 | 1-Acetyl-2-[1-(2-naphthyl)ethyl]benzene | AA009EKY | MFCD16251169
1246817-73-1 | 4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid-d4 Phenyl Ester | AA009EU1